학술논문

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Document Type
Article
Author
Agajanian, RichyAhmad, RizvanaAktas, BahriyeAlencar, Victor HugoAmadori, DinoAndrade, JurandyrAndré Franke, FábioAngiolini, CatiaAogi, KenjiroArmor, JessArpornwirat, WichitAssersohn, LauraAudeh, WilliamAulitzky, WalterAzevedo, SergioBartoli, Maria AlejandraBatista Lopez, NorbertoBianconi, MaríaBiganzoli, LauraBirhiray, RuemuBitina, MariannaBlachy, RonBlackwell, KimberlyBlanchard, RitaBlanchet, PauletteBoiangiu, IonBower, BarbaraBrezden-Masley, ChristineBrufsky, AdamBudde, LeanneCaguioa, PriscillaCalvo, LourdesCampone, MarioCarroll, Robert R.Castro, HugoChan, ValorieCharu, VeenaCinieri, SaverioClemens, MichaelConejo, Emilio AlbaCôrtes, EduardoCoudert, BrunoCronemberger, EduardoCubero, DanielDakhil, ShakerDaniel, BrookeDavidson, NevilleDe Fatima Gaui, MariaDe La Cruz, SusanaDel Pilar, MariaDelgado, GilsonEllerton, John A.Estuardo, CesarFehrenbacher, LouisFerrero, Jean-MarcFlynn, Patrick J.Foszczynska-Kloda, MalgorzataFranco, SandraFujii, HirofumiGallagher, ChrisGamucci, TeresaGiacomi, NoraGil I Gil, MiguelGonzalez Martin, AntonioGorbunova, VeraGotovkin, EugenyGreen, NathanGrincuka, ElzaGrischke, Eva-MariaHansen, VincentHargis, JeffreyHauschild, MaikHegg, RobertoHendricks, CarolynHermann, RobertHoff, PauloHoriguchi, JunHornedo Muguiro, JavierIacobelli, StefanoInoue, KenichiIsmael, GustavoItoh, YoshinoriIwata, Dr HirojiJendiroba, DaviJochim, RosaJones, AlisonJust, MarianneKallab, AndreKarwal, MarkKashiwaba, MasahiroKato, GiraldoKaufman, Peter A.Kellokumpu-Lehtinen, PirkkoKirsch, AndreasKiselev, IgorKlein, PaulaKohno, NorioKopp, MikhailKostovska-Maneva, LiljanaKotliar, MauricioKudaba, IvetaKümmel, SherkoKuroi, KatsumasaLacava, JuanLatini, LucianoLee, Soo ChinLichinitser, MikhailLobo, ChristopherMaintz, ChristophManeecahvakajorn, JedzadaMarmé, AlexanderMartinez, GloriaMasuda, NorikazuMatwiejuk, MarioMerculov, VladimirMichaelson, RichardMiguel, LuisMonroy, HernandezMontemurro, FilippoMorales, SerafinMoura, RodrigoMueller, VolkmarMulatero, CliveNakagami, KazuhikoNakayama, TakahiroNeidhart, JeffNguyen, AnNishimura, ReikiOgata, HarukiO'reilly, SusanO'rourke, TimothyOtero Reye, DouglasOuyang, XuenongPatel, RaviPatel, TaralPedrini, Jose LuizPereira, RodrigoPerez, AlejandraPeterson, CarolPienkowski, TadeuszPinczowski, HelioPolikoff, JonathanPolkowski, WojciechPrice, Paola EdithPrill, SuePriou, FrankPurkalne, GuntaPyrhoenen, SeppoQuackenbush, RobertRai, YoshiakiRibelles, NuriaRo, JungsilRobinson, AnneRobles, RobertRodriguez, GladysRoman, LasloSaji, ShigehiraSanchez-Rovira, PedroSato, NobuakiSchmidt, MarcusSchumacher, ClaudiaSenecal, FrankSharma, PriyankaShen, ZhenzhouShirinkin, VadimSimoncini, EddaSirisinha, ThitiyaSmith, RaymondSohn, Joo-HyukSoldic, ZeljkoSoria, TaniaSpicer, DarcySrimuninnimit, VichienSriuranpong, ViroteStaroslawska, ElzbietaStefanovski, PetarSunpaweravong, PatrapimTaguchi, JulieTakeda, KojiTellez-Trevilla, GabrielThomas, RandallThomssen, ChristophToache, ZetinaTokuda, YutakaTomczak, PiotrTosello, CeliaTsugawa, KoichiroTudtud, DennisUeno, TakayukiVan Eyll, BrigitteVarela, MirtaVasev, NikolaVrbanec, DamirWang, XiaojiaWang, LiweiWatanabe, JunichiroWaterhouse, DavidWesenberg, BirgittaWheatley, DuncanWong, Zee WanYadav, SanjayYardley, DeniseYau, Tsz-KokYeo, WinnieYing, ChengYoun Oh, DoSwain, Sandra MMiles, DavidKim, Sung-BaeIm, Young-HyuckIm, Seock-AhSemiglazov, VladimirCiruelos, EvaSchneeweiss, AndreasLoi, ShereneMonturus, EstefaníaClark, EmmaKnott, AdamRestuccia, EleonoraBenyunes, Mark CCortés, Javier
Source
In The Lancet Oncology April 2020 21(4):519-530
Subject
Primary Research
Articles
Language
ISSN
1470-2045